APHISNonrulemakingAPHIS-2022-0076

Who commented on this docket

Request for Information; Identifying Ambiguities, Gaps, Inefficiencies, and Uncertainties in the Coordinated Framework for the Regulation of Biotechnology

1 organizations filed 1 public comment on Request for Information; Identifying Ambiguities, Gaps, Inefficiencies, and Uncertainties in the Coordinated Framework for the Regulation of Biotechnology, at the Animal and Plant Health Inspection Service. The comment window closed 1271d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 1271d ago

Abstract

The National Biotech and Biomanufacturing Initiative (NBBI), launched through Executive Order 14081, identified biotechnology regulation clarity and efficiency as a priority of the Administration. Thus, the White House Office of Science and Technology Policy (OSTP)—on behalf of the primary agencies that regulate the products of biotechnology, the U.S. Environmental Protection Agency (EPA), the Food and Drug Administration (FDA), and the U.S. Department of Agriculture (USDA)—requests relevant data and information, including case studies, that may assist in identifying any regulatory ambiguities, gaps, inefficiencies, or uncertainties in the Coordinated Framework for the Regulation of Biotechnology, particularly with regard to new and emerging biotechnology products. The information provided will inform regulatory agency efforts to improve the clarity and efficiency of the regulatory processes for biotechnology products, as described in Executive Order 14081. Interested persons and organizations are invited to submit comments on or before 5 p.m. ET February 3, 2023.

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.